Who is involved?


The sixteen clinics across Nebraska have formed a Limited Liability Corporation.

 

ACO Name and Location

SERPA-ACO, LLC
Crete, Nebraska

ACO Primary Contact:
Joleen TenHulzen Huneke, Chief Executive Officer
jthserpa@rccn.info
(402) 826-3737

Organizational Information:

ACO Participants:

      Joined 1/1/2017: 

  • Bloomfield Medical Clinic, P.C. - Bloomfield, NE
  • Falls City Family Practice, P.C. - Falls City, NE

     

ACO participants in joint ventures between ACO professional and hospitals:

No participants are involved in a joint venture between ACO professionals and hospitals

 

ACO Governing Body:

  • Patrick Hotovy, MD, Voting Member, ACO Provider/Supplier, President, York Medical Clinic
  • Logan Pritchard, DO, Voting Member, ACO Provider/Supplier, Vice-President, Family Medical Center of Hastings
  • Jason Bespalec, MD, Voting Member, ACO Provider/Supplier, Secretary/Treasurer, Fillmore County Medical Center
  • Gerald Luckey, MD, Voting Member, ACO Provider/Supplier, Executive Committee--At-Large Member, Butler County Clinic
  • Eileen Rock, MD, Voting Member, ACO Provider/Supplier, Executive Committee--At-Large Member, Lincoln Family Wellness
  • Ed Discoe, MD, Voting Member, ACO Provider/Supplier, Executive Committee--At-Large Member, Columbus Medical Clinic
  • Jason Citta, MD, Voting Member, ACO Provider/Supplier, Midlands Healthcare Group
  • Riley Eckmann, MD, Voting Member, ACO Provider/Supplier, Bloomfield Medical Clinic
  • Ed Ford, MD, Voting Member, ACO Provider/Supplier, Plum Creek Medical Group
  • Matt Jacobsen, MD, Voting Member, ACO Provider/Supplier, Lincoln Family Medical Group
  • Jeff Kasselman, MD, Voting Member, ACO Provider/Supplier, LifeCare Family Medicine of Bellevue
  • Robert Messbarger, MD, Voting Member, ACO Provider/Supplier, Family Practice Associates
  • David Minnick, MD, Voting Member, ACO Provider/Supplier, Central Nebraska Medical Clinic
  • Dan Rosenquist, MD, Voting Member, ACO Provider/Supplier, Columbus Family Practice
  • Allan Tramp, MD, Voting Member, ACO Provider/Supplier, Falls City Family Practice
  • John West, MD,Voting Member, ACO Provider/Supplier, McCook Clinic
  • Beth Klosterman, Voting Member, Medicare Beneficiary Representative

Key ACO Clinical and Administrative Leadership:

Joleen TenHulzen Huneke, Chief Executive Officer
jthserpa@rccn.info

Dale Michels, MD, Chief Medical Officer
cmo@serpa-aco.org

Denise Mainquist, Compliance Officer

Gerald Luckey, MD, Quality Assurance/Improvement Officer

LaGreer Randolph, Data Specialist
lrandolph@serpa-aco.org

Janet Steffen, RN, Director of Clinical Care Coordination
jsteffen@serpa-aco.org

Associated committees and committee leadership:

  • Quality Assurance/Improvement - Gerald Luckey, MD, Chair
  • Compliance - Dan Rosenquist, MD, Chair
  • Finance - Jason Bespalec, MD, Chair
  • Contracting - Stewart Hinrchsen, Chair
  • Marketing/Communications - Beth Klosterman and Tess Sinner, Co-chairs
  • Information Management - Brian Rokusek, Chair

Types of ACO Participants or combinations of participants that formed the ACO: 

Network of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Agreement Period beginning 2013, Performance Year 1:       $0
  • Agreement Period beginning 2013, Performance Year 2014:  $0
  • Agreement Period beginning 2013, Performance Year 2015:  $0

Shared Savings Distribution

  • Agreement Period beginning 2013, Performance Year 1:       $0
  • Agreement Period beginning 2013, Performance Year 2014:  $0
  • Agreement Period beginning 2013, Performance Year 2015:  $0

Payment Rule Waivers

       No, our ACO does not utilize the SNF 3-Day Rule Waiver.

Quality Performance Results

2015 Quality Performance Results Table



Measure 
Number
Performance Measure 2015 Reporting Period
ACO 
Performance 
Rate
Mean 
Performance 
(SSP - ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 78.98 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 93.09 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 92.64 91.94
ACO-4 CAHPS: Access to Specialists 87.82 83.61
ACO-5 CAHPS: Health Promotion and Education 55.57 59.06
ACO-6 CAHPS: Shared Decision Making 74.37 75.17
ACO-7 CAHPS: Health Status/Functional Status 74.62 72.30
ACO-34  CAHPS: Stewardship of Patient Resources* 29.47 26.87
ACO-8  Risk Standardized, All Condition Readmission 14.45 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission 18.33 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 50.99 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure* 72.43 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 62.46 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in 
Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)
1.29 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure 
(AHRQ Prevention Quality Indicator (PQI) #8)
0.72 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 87.1% 76.22%
ACO-39 Documentation of Current Medications in the Medical Record* 90.76% 84.07%
ACO-13 Falls: Screening for Future Fall Risk 74.92% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization 84.44% 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 88.64% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 61.3% 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 93.77% 90.16%
ACO-18  Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 74.53% 42.25%
ACO-19  Colorectal Cancer Screening  71.51% 60.06%
ACO-20  Breast Cancer Screening 74.57% 65.67%
ACO-21  Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 49.11% 70.04%
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27  Diabetes Mellitus: Hemoglobin A1c Poor Control 10.14% 20.38%
ACO-41 Diabetes: Eye Exam* 67.62% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure 76.16% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 86.61% 83.92%
ACO-31 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy 
- for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)
84.58% 77.73%

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.

*= Measure required beginning Reporting Year 2015.

N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

 

2012 - 2014 Quality Performance Results Table

Measure Number

Performance Measure

2012 Reporting Period

2013 Reporting Period

2014 Reporting Period

ACO Performance Rate

Mean Performance Rate for All ACOs

ACO Performance Rate

Mean Performance Rate for All ACOs

ACO Performance Rate

Mean Performance Rate for All ACOs

ACO #1 Getting Timely Care, Appointments, and Information Not in operations Not in operations 82.28 81.48 82.35 80.13
ACO #2 How Well Your Doctors Communicate Not in operations Not in operations 92.60 92.96 93.48 92.39
ACO #3 Patients’ Rating of Doctor Not in operations Not in operations 92.36 92.06 92.22 91.58
ACO #4 Access to Specialists Not in operations Not in operations 84.65 85.12 84.62 83.97
ACO #5 Health Promotion and Education Not in operations Not in operations 55.41 53.38 56.25 58.29
ACO #6 Shared Decision Making Not in operations Not in operations 74.44 74.53 76.33 74.6
ACO #7 Health Status/Functional Status Not in operations Not in operations 70.78 71.12 73.07 71.1
ACO #8 Risk Standardized, All Condition Readmissions Not in operations Not in operations 14.07 14.90 14.68 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults Not in operations Not in operations 1.17 1.17 0.92 1.08
ACO #10 ASC Admission: Heart Failure Not in operations Not in operations 0.75 1.20 0.84 1.19
ACO #11 Percent of Primary Care Providers who Qualified for EHR Incentive Payment Not in operations Not in operations 89.36% 66.21% 100.00% 76.71%
ACO #12 Medication Reconciliation Not in operations Not in operations 92.51% 73.56% 98.39% 82.61%
ACO #13 Falls: Screening for Fall Risk Not in operations 2Not in operations 69.59% 39.57% 76.81% 45.60%
ACO #14 Influenza Immunization Not in operations Not in operations 67.95% 56.93% 78.97% 57.51%
ACO #15 Pneumococcal Vaccination Not in operations Not in operations 79.24% 54.76% 88.25% 55.03%
ACO #16 Adult Weight Screening and Follow-up Not in operations Not in operations 54.33% 61.61% 58.46% 66.75%
ACO #17 Tobacco Use Assessment and Cessation Intervention Not in operations Not in operations 95.24% 84.01% 95.33% 86.79%
ACO #18 Depression Screening Not in operations Not in operations 49.36% 31.19% 69.35% 39.27%
ACO #19 Colorectal Cancer Screening Not in operations Not in operations 59.08% 59.30% 66.43% 56.14%
ACO #20 Mammography Screening Not in operations Not in operations 66.78% 62.05% 71.72% 61.41%
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years Not in operations Not in operations 90.83% 74.25% 63.48% 60.24%
ACO #22 Beneficiaries with diabetes who met the following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent) Not in operations N/A 77.83% N/A 80.61% N/A
ACO #23 Beneficiaries with diabetes who met the following criteria: Low Density Lipoprotein (LDL) (< 100 mg/dL) Not in operations N/A 56.49% N/A N/A N/A
ACO #24 Beneficiaries with diabetes who met the following criteria: Blood Pressure (BP) < 140/90 Not in operations N/A 74.71% N/A 75.58% N/A
ACO #25 Beneficiaries with diabetes who met the following criteria: Tobacco Non-Use Not in operations N/A 86.04% N/A 88.33% N/A
ACO #26 Beneficiaries with diabetes who met the following criteria: Aspirin Use Not in operations N/A 95.57% N/A 89.60% N/A
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) Not in operations Not in operations 13.96% 22.11% 9.16% 20.35%
ACO #28 Percent of beneficiaries with hypertension whose BP < 140/90 Not in operations Not in operations 71.95% 67.79% 75.50% 68.02%
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl Not in operations Not in operations 51.45% 55.44% N/A N/A
ACO #30 Percent of beneficiaries who use Aspirin or other antithrombotic Not in operations Not in operations 82.79% 76.35% 88.21% 80.79%
ACO #31 Beta-Blocker Therapy for LVSD Not in operations Not in operations 87.50% 79.82% 88.65% 82.71%
ACO #32 Percent of beneficiaries with CAD who met the following criteria: Drug Therapy for Lowering LDL-Cholesterol Not in operations N/A 58.09% N/A N/A N/A
ACO #33 Percent of beneficiaries with CAD who met all following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) Not in operations N/A 82.21% N/A 83.49% N/A
               
               
Note: ASC = ambulatory sensitive conditions, COPD = chronic obstructive pulmonary disease,, EHR = electronic health record, IVD = ischemic vascular disease, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.      
             

 

;